FPE-022

N/A

Report date: 2025/07/18 17:31:38

Base Information

Drug NameFPE-022
Drug Alias NameFPE-022
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor superfamily member 15 modulatorsInterleukin-10 modulators
TargetsTumor necrosis factor superfamily member 15Interleukin-10
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangdong Fapon Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Fapon Biopharma Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A